Neurocrine Biosciences (NBIX)
(Delayed Data from NSDQ)
$138.97 USD
-1.12 (-0.80%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $138.92 -0.05 (-0.04%) 7:58 PM ET
2-Buy of 5 2
C Value A Growth F Momentum C VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/01/2024
Time: BMO |
3/2024 | $1.04 | -35.58% |
Earnings Summary
For their last quarter, Neurocrine Biosciences (NBIX) reported earnings of $1.44 per share, beating the Zacks Consensus Estimate of $1.13 per share. This reflects a positive earnings surprise of 27.43%. Look out for NBIX's next earnings release on May 01, 2024. For the next earning release, we expect the company to report earnings of $1.04 per share, reflecting a year-over-year increase of 231.65%.
Earnings History
Price & Consensus
Zacks News for NBIX
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)?
NBIX: What are Zacks experts saying now?
Zacks Private Portfolio Services